Aftozne ulceracije kao multifaktorijalni problem by Ana Ujević et al.
Acta Clin Croat,  Vol. 52,  No. 2,  2013 213
Acta Clin Croat 2013; 52:213-221 Review
APHTHOUS ULCERS AS A MULTIFACTORIAL PROBLEM
Ana Ujević1, Liborija Lugović-Mihić2, Mirna Šitum2, Luka Ljubešić2, Josip Mihić3 and Nina Troskot2
1Vukić Private Dental Clinic; 2Clinical Department of Dermatovenereology, Sestre milosrdnice University 
Hospital Center, Zagreb; 3Department of Surgery, Dr Josip Benčević General Hospital, Slavonski Brod, Croatia
SUMMARY – Recurrent aphthous stomatitis (RAS) is a disorder characterized by recurrent 
ulcerations limited to the oral mucosa. Many specialists and researchers in the domain of oral me-
dicine and other fields do not recognize a single disease in RAS, but several pathologic states with 
similar clinical characteristics. Even though the real cause is unknown, there are some predisposing 
factors such as anemia caused by the lack of iron, folic acid and vitamin B, neutropenia, local trauma, 
emotional stress, metabolic disorders, hormonal disorders and chronic diseases, which cause immu-
nodeficiency. This disease can appear in three clinical forms: small aphthous ulcers, large aphthous 
ulcers and herpetiform aphthous ulcers. The treatment of this type of disorder involves local or 
systemic use of corticosteroids, immunostimulants and vitamin therapy. Due to the association of 
aphthous ulcers with various other diseases, cooperation among multiple fields of medicine and a 
multidisciplinary approach are necessary. 
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Introduction
Recurrent aphthous stomatitis (RAS) is a disorder 
characterized by recurrent ulcerations limited to the 
oral mucosa. Many specialists and researchers in the 
domain of oral medicine and other fields do not rec-
ognize a single disease in RAS, but several pathologic 
states with similar clinical characteristics. The pos-
sible etiologic factors in RAS include immune disor-
ders, hematologic diseases, hypovitaminoses and nu-
tritional deficiencies, allergy, psychological disorders, 
and others. RAS appears in approximately 20% of the 
general population, its frequency ranging from 5% to 
50% in particular ethnic and socioeconomic groups1. 
RAS is classified according to clinical character-
istics in three clinical forms: small aphthous ulcers 
(aphtha minor), large aphthous ulcers (aphtha maior, 
Sutton’s disease, periadenitis mucosa necrotica re-
currens), and herpetiform aphthous ulcers (aphthae 
herpetiformis). Small aphthous ulcers, which appear 
in more than 80% of patients, are less than 1 cm in 
diameter and heal without a scar. Large aphthous ul-
cers are more than 1 cm in diameter, take longer time 
to heal (up to a month) and leave scars. Herpetiform 
aphthous ulcers are rare forms of RAS and are con-
sidered a separate clinical entity, which occurs in the 
form of multiple small erosions that affect the coating 
mucosa. 
Etiology
Once it has been considered that RAS is a form 
of recurrent herpes simplex virus (HSV) infection, 
so some still mistakenly call it “herpes”. Numerous 
studies conducted during the past several decades 
have confirmed that HSV is not the causative agent of 
RAS, which is additionally corroborated by the fact 
that the specific and effective antiviral treatment used 
in HSV has proved useless in the treatment of RAS2. 
The association of RAS with other herpes viruses, 
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such as Varicella zoster and Cytomegalovirus, is still un-
clear and a subject of numerous researches3,4.                                 
In recent times, RAS is discussed as a clinical syn-
drome that occurs through the effect of several factors 
(Table 1). The most important etiologic factors are 
heredity, mineral and vitamin insufficiencies, allergy, 
hematologic and immune diseases5.
Of all the presumed causes, the best documented is 
heredity. It has been determined that 30%-40% of pa-
tients with RAS have positive family history of RAS6. 
Miller et al. studied 1303 children from 530 families 
and showed that children of RAS positive parents had 
an increased predisposition to develop this disease7. 
According to research reports, children whose parents 
are RAS positive have 90% chance to develop RAS, 
whilst the children of healthy parents have only 20% 
probability to develop this disease8. Numerous studies 
(offering more evidence speaking for the hereditary 
etiology of the disorder) have detected specific HLA 
antigens in RAS patients, especially in certain ethnic 
groups9.
In some patient groups with RAS, the possible 
causative factors are mineral and vitamin insuffi-
ciency, such as the lack of serum iron, folate or vita-
min B12, and zinc, and their frequency is estimated 
at 5%-15%10. The results have shown that in 75% of 
patients with RAS, clinical improvement occurs af-
ter replacement treatment of the lacking minerals and 
vitamins11. It is possible that nutritional deficiency is 
a consequence of malabsorption syndromes, such as 
celiac disease, which should also be examined during 
diagnostic procedure12.
Numerous researches of RAS etiology have fo-
cused on immune disorders. Earlier works have 
pointed to an autoimmune disorder or hypersensi-
tivity to microorganisms of the oral cavity, such as 
Streptococcus sanguis13. Later researches, with the help 
of sophisticated immunologic tests, have increasingly 
proved the role of cellular cytotoxicity dependent on 
antibodies and disorders of a subpopulation of lym-
phocytes14-16. Thomas et al. demonstrated increased 
T-lymphocyte cytotoxicity against oral epithelial cells 
in RAS patients14. Studies by Pedersen et al. and oth-
er authors demonstrated changes of the CD4:CD8 
lymphocyte ratio or a disorder in the function of 
numerous cytokines in the skin and mucosa17,18. In 
peripheral blood of patients with RAS, a predomi-
nance of Th1-cytokines and a decrease in the number 
of CD4(+)CD25(+high) regulatory T lymphocytes 
have been determined, indicating activation of pri-
marily Th1-cytokine immune response19. Decreased 
phagocytic functions of salivary and peripheral blood 
neutrophils have also been proven in RAS patients 
in comparison to healthy subjects20. However, further 
research is necessary to determine immune changes 
in RAS patients.
Also, it has been shown that an allergic reaction 
to food, especially to cow’s milk, takes part in RAS 
 Table 1. The most significant characteristics of recurrent aphthous stomatitis 
            Etiology         Related systemic diseases          Therapy
-  Heredity
-  Deficiency of vitamins and 
minerals
-  Immune disorders
-  Food allergies
-  Physical trauma of mucosa
-  Psychological stress and 
anxiety
-  Behçet’s disease (oral/perianal/genital ulcers + 
eye inflammation + arthritis + skin lesions)
-  Reiter syndrome (oral changes + polyarthritis 
+ nonspecific inflammation of urogenital tract 
and intestinal mucosa + ocular changes + 
mucocutaneous lesions)
-  MAGIC syndrome (oral/genital ulcers + 
polychondritis)
-  Sweet syndrome (oral ulcers + papules and 
nodules on skin of the head, neck, and 
extremities)
-  PFAFA syndrome (elevated temperature + 
aphthous ulcers + pharyngitis + adenitis)
-  Cylic neutropenia
-  Primary/secondary immunodeficiency
Local:
-  Neutral preparation, e.g., 
Orabase
-  High/low-potent local 
steroid preparation
-  Anti-inflammatory agents 
(amlexanox, benzydamine)
-  Local tetracyclines, etc.
Systemic:
-  Systemic corticosteroids
-  Immunosuppressants
-  Appropriate replacement 
therapy (where necessary)
-  Laser, etc.
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etiology21. In cases of refractory forms of the disease, 
the effectiveness of an elimination diet has been 
proven in patients with suspect or proven food aller-
gy, such as to cow’s milk, cheese, grains and flour22. 
It has been proven that 33.3% of RAS patients show 
positive allergic reactions to vanillyn23. Sodium lau-
ryl sulfate (SLS), a detergent present in tooth pastes, 
is also mentioned as one of the possible causative 
agents of RAS24. However, other studies have shown 
that the application of tooth pastes without SLS does 
not significantly affect the development of aphthous 
ulcers25.
In addition, researches on the effect of smoking on 
RAS were conducted and showed that quitting smok-
ing increaed the frequency and intensity of RAS26. 
However, more recent researches show that the pro-
tective effect of smoking is only observed in heavy 
smokers who smoke more than 20 cigarettes per day 
or longer than 5 years. Still, no significant association 
between smoking intensity or duration and clinical 
severity of RAS lesions has been shown27.
According to some researches, a trauma of oral 
cavity is one of the most frequent triggers. So, RAS 
can be triggered by physical trauma, such as the one 
caused by abrasion by a toothbrush, laceration by 
a sharp or abrasive food (such as toast, chips, and 
muesli), a bite, or tooth or brace loss. Also, other fac-
tors, such as chemical irritation or thermal injury, can 
lead to ulceration. In addition, gastrointestinal dis-
ease should be examined, for example, celiac disease 
or gluten enteropathy, intolerance to gluten, can also 
be the cause of RAS28. The role of Helicobacter (H.) 
pylori as a causative agent of RAS remains controver-
sial, although the relationship between H. pylori and 
RAS has been suggested. Because of the histologic 
similarities between peptic ulcers and RAS and the 
identified role of H. pylori in peptic ulcer, the possibil-
ity of bacterial involvement in the progression of RAS 
has been suggested, but the results obtained did not 
confirm these assumptions29. Other possible etiologic 
factors of RAS include psychological stress, anxiety, 
and others. 
Clinical Characteristics
The first appearance of RAS most commonly 
occurs during the second decade of life and can be 
catalyzed by lesser trauma, menstruation, upper re-
spiratory system infections, or contact with certain 
foods. The disease begins with prodromal sensation 
of burning, 2 to 48 hours before the appearance of 
ulcers. During this initial period, usually local ery-
thema develops. In several hours, small white papules 
appear, which ulcerate and gradually increase within 
the next 48 to 72 hours. In RAS, the individual le-
sions are round, symmetric and shallow (similar to 
viral ulcers, but without the remainder of epithelium 
on the lesion edges, which can be noticed after vesicle 
ruptures) in comparison with the diseases with ir-
regular ulcers (erythema multiforme, pemphigus and 
pemphigoid)30. Frequently, multiple lesions are pres-
ent, whose size, number and frequency vary. Lesions 
appear most commonly on the cheek and lip mucosa, 
but do not appear on keratinized mucosa, on hard 
palate and gingival mucosa. In milder forms of RAS, 
lesions reach the size of 0.3 to 1.0 cm, begin to heal 
within a week, and heal completely without a scar in 
10 to 14 days31.
Depending on the size, number and appearance, 
aphthous ulcers can be classified in three clinical 
forms: small or minor aphthous ulcers, large or major 
aphthous ulcers, and herpetiform aphthous ulcers. 
Small or minor aphthous ulcers are up to 1 cm in di-
ameter, there are several of them simultaneously, and 
they heal spontaneously within 7 to 10 days, with no 
scars (Fig. 1)32. Large or major aphthous ulcers are 
greater than 1 cm in diameter and less in number 
than small aphthous ulcers (Fig. 2)32. Predisposing 
locations for the occurrence of large aphthous ulcers 
are the lip, soft palate and pharyngeal mucosa, and 
Fig. 1. Minor aphthous ulcer32.   
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they heal up to a month leaving a scar. Major aph-
thous ulcers frequently appear in human immuno-
deficiency virus (HIV)-positive patients, which is 
explained by a disorder of immunoregulatory abili-
ties and potentiated with HIV disease. Herpetiform 
aphthous ulcers are the rarest form characterized by 
a large number of smaller ulcers whose size is several 
millimeters in diameter, which appear predominant-
ly in the anterior part of oral cavity, most frequently 
on the vestibule, lip, tongue and sublingual mucosa 
(Fig. 3)32. These are distributed over larger surfaces 
of the mucosa and have been named herpetiform, 
although the only connection to the HSV is their 
name.
Namely, it is important that aphthous ulcers exclu-
sively appear on less keratinized, coating oral mucosa, 
and never on the gingiva, hard palate or transitional 
mucosa (like HSV). Most RAS patients have between 
2 to 6 lesions in every episode of the disease, and such 
episodes occur several times per year. This disease is 
very unpleasant, even in the mild, minor form, and 
is a real disability for persons with serious and fre-
quent lesions, especially if they appear in the form of 
large, major aphthous ulcers, where a large surface of 
the mucosa can be covered with deep and painful ul-
cers that can merge together. Lesions are excruciating 
and create problems with speaking and swallowing. 
They can last for months and consequently are misdi-
agnosed, as they may be similar to squamous cell car-
cinoma, chronic granulomatous disease, drug reaction 
or pemphigoid. Lesions heal slowly and leave scars, 
which can result in decreased mobility of the uvula 
and the tongue, and damage to parts of the mucosa. 
Diagnosis
RAS is the most common cause of recurrent ul-
cers of the oral cavity and is diagnosed by exclusion 
of other conditions. Detailed history and clinical ex-
amination should help differentiate RAS from other 
diseases. So, RAS should be differentiated from pri-
mary acute lesions (viral stomatitis), chronic multiple 
lesions (pemphigoid), and other possible sources of 
primary recurrent ulcers (connective tissue disease, 
drug reactions and skin diseases). It is important to 
examine potential lesions on the skin, eyes, genitals, 
and the exiting part of the colon, especially if the pa-
tient himself mentions these symptoms. Laboratory 
tests should be done in all cases of disease exacerba-
tion, that is, its appearance after age 25. It is necessary 
to obtain biopsy of the mucosa in case of suspicion of 
a granulomatous disease (such as Crohn’s disease or 
sarcoidosis), or if precancerous state, cancer or pem-
phigus/pemphigoid is suspected30,31.
In patients with a more severe form of aphthous 
ulcers, one should determine the levels of iron, folate, 
vitamin B12, ferritin, serum zinc, and exclude con-
nective tissue disease. Patients should also be referred 
to an internist to exclude malabsorption syndrome, 
food allergy, gluten-sensitive enteropathy (celiac dis-
ease), etc.22. Also, it is necessary to examine the pos-
sibility of HIV infection because these patients are 
predisposed to develop large aphthous ulcers. Thereby, 
a multidisciplinary approach is necessary31.
The influence of drugs as the causes of oral ulcers 
is also possible, particularly in differential diagnosis 
of RAS. Thereby, direct contact between drugs and 
Fig. 3. Herpetiform aphthous ulcers32.Fig. 2. Major aphthous ulcer32.    
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oral mucosa may induce chemical burn or local hy-
persensitivity, or sometimes drug-induced oral ulcer-
ations, possibly with cutaneous or systemic manifesta-
tions. Thus, oral ulcerations following the symptoms 
of burning mouth, metallic taste, dysgeusia or ageusia 
are strongly suggestive of a pharmacological origin. 
Most of the drugs able to induce solitary oral ulcer-
ations are commonly prescribed in rheumatology, 
cardiology, psychiatry, etc.33. There is also the possi-
bility of oral manifestations with drug-induced leu-
kopenia, e.g., due to analgesics, antibacterial agents, 
phenothiazines, antithyroid and cytotoxic agents, car-
bamazepine, etc. Cyclic neutropenia is a rare cause of 
recurrent oral ulceration and periodontitis that most 
frequently starts in infancy or childhood. During 
neutropenic episodes, the most common symptoms 
are fever and oral ulceration. 
It is significant that aphthous ulcers exclusively 
appear on less keratinized, coating oral mucosa, and 
never on the gingiva, hard palate and transitional lip 
mucosa (as in HSV infection). Because the appearance 
of RAS is possibly one of the first signs and character-
istics of multiple disorders (e.g., Behçet’s disease and 
Reiter syndrome), it is recommended to pay attention 
to other disease symptoms (ocular, genital, arthritic 
and others). Thus, RAS is usually the first sign of Be-
hçet’s disease, the ulcers may precede other symptoms 
by several years, and the patients usually have perianal 
and genital ulcers, which are deeper and more pain-
ful. Recurrence of aphthous ulcers is possible in Reiter 
syndrome (an autoimmune, recurrent, nonsuppurative 
polyarthritis with nonspecific inflammation of uro-
genital tract and intestinal mucosa, ocular changes 
and mucocutaneous lesions)2. RAS can sometimes 
be a manifestation of other systemic diseases such as 
the mouth and genital ulcers with inflamed cartilage 
(MAGIC) syndrome, Sweet syndrome, periodic fever, 
aphthous stomatitis, pharyngitis and cervical adenitis 
(PFAPA) syndrome, and others6. Oral ulcers similar 
to aphthous ulcers are possible in Sweet syndrome 
(febrile neutrophilic dermatosis), which appear idio-
pathically or with numerous conditions (malignant 
carcinomas, infections, systemic disorders, drugs) in 
the form of confluent skin papules and nodules, with 
possible pustules and bullae. The PFAPA syndrome is 
a rare clinical syndrome of unknown etiology, which 
usually occurs in children. 
When finding recurrent oral ulcers, on differential 
diagnosis it is also necessary to consider skin diseases 
such as erythema multiforme, pemphigus and pem-
phigoid, drug eruptions, contact reactions, squamous 
cell carcinoma, and infectious diseases, such as lesions 
caused by HSV, Coxsackie stomatitis, and syphilis 
(ulcus durum)30,31,34. In addition to this, it is neces-
sary to consider granulomatous diseases (e.g., Crohn’s 
disease, sarcoidosis).
Treatment 
Although the majority of RAS cases spontaneously 
enter remission, it is necessary to treat the patients be-
cause the disease is very unpleasant. Most commonly 
used RAS therapy are local corticosteroids, which de-
crease pain and duration of ulcers, but have no effect 
on future occurrence of new lesions. 
Therapeutic approaches for RAS depend on disease 
severity. In mild cases with 2-3 small lesions, protec-
tive therapy with preparations that have the ability of 
adhesion to oral mucosa (for example, Orabase) is suf-
ficient. If there is pain accompanying small lesions, 
it can be removed by use of local anesthetics or local 
diclofenac. In patients with more developed disease, 
local steroid preparations (such as hydrocortisone, flu-
ocinonide, betamethasone, triamcinolone or clobeta-
sol) can be used to cover the lesions, to decrease the 
size of ulcers and to shorten the time of healing. They 
are applied 2-3 times per day (after meals and before 
bedtime), most frequently mixed in Orabase, which 
prevents quick washout of the medicine through sa-
liva and improves therapeutic effect due to longer con-
tact with larger lesions. Thereby, hydrocortisone and 
triamcinolone preparations are popular because nei-
ther causes significant adrenal suppression, but they 
often fail to stop recurrence. On the other hand, be-
tamethasone, fluocinonide, fluocinolone, fluticasone 
and clobetasol are more potent and effective, but they 
carry the possibility of some adrenocortical suppres-
sion and predisposition to candidiasis35. Longer con-
tact with large lesions can also be achieved by the ap-
plication of pieces of gauze soaked for 15-30 minutes 
in local steroids. 
Anti-inflammatory agents can help and a spectrum 
of topical agents such as benzydamine and amlexanox 
may decrease the time necessary for healing of RAS 
lesions. Thus, amlexanox paste and local tetracyclines 
218 Acta Clin Croat,  Vol. 52,   No. 2,  2013
Ana Ujević et al. Aphthous ulcers as a multifactorial problem
can be applied as solutions for the mouth (250 mg cap-
sule in 10 mL of water as a solution for mouth rinsing) 
or soaked in gauze. On doing so, caution is necessary 
when locally applying tetracyclines because they are 
contraindicated in children younger than 12 years due 
to their effect of tooth discoloration. However, topi-
cal tetracyclines may reduce the severity of ulceration, 
but they do not alter the recurrence rate. Refractory 
large aphthous ulcers demand intralesional/perile-
sional corticosteroid instillation. It is also necessary 
to maintain good mouth hygiene, mouth solutions on 
the basis of chlorhexidine or triclosane being of help. 
Chlorhexidine gluconate mouth rinses reduce the 
severity and pain, but not the frequency of ulceration.
When RAS does not respond to the mentioned 
local therapy and measures, it is necessary to consider 
systemic therapy, for example, immunomodulators 
under physician control, who estimates the potential 
benefits against the risks of application concerning the 
side effects of these medications. 
Few, if any, of other medications used for RAS 
have undergone serious scientific evaluation35. These 
include transfer factor, gamma-globulin therapy, so-
dium cromoglycate lozenges, dapsone, colchicine, 
pentoxifylline, levamisole, colchicine, azathioprine, 
prednisolone, azelastine, alpha 2-interferon, cy-
closporin, deglycerinated liquorice, 5-aminosalicylic 
acid (5-ASA), prostaglandin E2 (PGE2), sucralfate, 
diclofenac, aspirin, etc. Thalidomide 50-100 mg daily 
is effective against severe RAS, although ulcers tend 
to recur within 3 weeks, but  adverse effects dissuade 
most physicians from its use (teratogenicity, neuropa-
thy, and others). 
Aside from the supervising dentist and family 
medicine specialist, on administering therapy special-
ists who monitor patients for the possible side effects 
and who adequately respond to their occurrence should 
be involved. Research on the effectiveness of laser on 
RAS lesions demonstrated faster pain decrease and 
complete lesion regression in 75% of patients, in com-
parison to patients on corticosteroids36.   
It is also necessary to correct the potential caus-
ative factors or systemic disorders that could be in the 
background of RAS. If the patients are predisposed to 
develop RAS, it is necessary to warn them not to trau-
matize oral mucosa while brushing the teeth (by using 
soft toothbrushes with a small head), and avoid hard 
and sharp food and other traumas of the mucosa. In 
case that oral hygiene products contain SLS, it is nec-
essary to change them. In patients with proven defi-
ciency of iron, folate, vitamin B12 or zinc, appropriate 
replacement therapy should be introduced. If an asso-
ciation with a certain type of food has been observed, 
it is necessary to avoid it and possibly undergo allergo-
logic testing (skin tests)34. In patients whose aphthous 
ulcers occur cyclically with menstrual cycles or as a 
reaction to the hormonal system established by oral 
contraceptive, it should be discontinued or switched 
to another one. It is necessary to exclude drugs that 
are a potential cause of RAS occurrence. Also, it is 
required to treat any systemic diseases related to oral 
aphthous ulcers.
Discussion
Aphthous ulcers or recurrent aphthous ulcers, rec-
ognized by the occurrence of round or oval recurrent 
painful ulcers on the oral mucosa, are characteristic 
of the disease. According to literature data, they af-
fect every fifth person at least once in their lifetime. 
Although the disease is of a benign character, the 
greatest challenges are subjective disturbances which 
appear and recur. Apart from other complications, it 
should be noted that RAS can sometimes lead to fa-
cial edema or elevated temperature, or even difficulty 
with swallowing, speaking or chewing. This can be 
partially attributed to the usual specific localization of 
aphthous changes on the mucosa, which is involved in 
many functions such as chewing, speaking, swallow-
ing, thus causing painful speech and mastication.
The diagnosis of aphthous ulcers is usually estab-
lished on the basis of a characteristic clinical picture 
and history, and subsequently, a wider work-up is 
undertaken to examine the possible association with 
some other disease. In the diagnostic procedure, it 
is significant that RAS lesions are round, symmetric 
and shallow (similar to viral ulcers, but without the 
remainder of epithelium on the lesion border, which 
can be observed after vesicle rupture), by which they 
differ from the diseases with irregular ulcers (e.g., 
erythema multiforme, pemphigus and pemphigoid). 
It should be emphasized that the appearance of RAS 
may be linked to some systemic disease, and some-
times with the appropriate work-up some related dis-
ease or syndrome can be discovered. Also, in case of 
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precancerous state or carcinoma in the differential di-
agnosis, biopsy is indicated or excision of the change 
with histopathologic analysis, as well as in non typical 
changes of granulomatous disease, pemphigus, pem-
phigoid, etc.  
Due to the association of manifestations of apht-
hous ulcers with various other diseases, cooperation 
between a number of specialties and a multidisci-
plinary approach are necessary. So, the topic has been 
researched and written about by oral pathologists, 
oral surgeons, immunologists, dermatologists, ENT 
specialists, pediatricians, gastroeneterologists, aller-
gologists, rheumatologists, infectologists, and various 
other specialties. Because the occurrence of RAS is 
possibly one of the first signs and features of multisys-
tem disorders, in patients with RAS it is recommend-
ed to always pay attention to other related symptoms 
(primarily ocular, genital and arthritic, and others). 
So, for example, RAS may be the first sign of Behçet’s 
disease, with the possible existence of ulcers several 
years before other symptoms. Also, the possibility of 
Reiter syndrome should be examined, which includes 
changes on multiple organs and changes in the oral 
cavity. Additionally, RAS can sometimes be a mani-
festation of some rarer syndromes, such as MAGIC, 
Sweet and PFAPA syndromes, and others. Also, there 
is a possibility of a rare condition, the PFAPA syn-
drome, which is a clinical syndrome of unknown eti-
ology and usually occurs in children.  
On the differential diagnosis, one should keep 
in mind the association with skin changes and the 
possibility of a primarily dermatologic disease, such 
as Sweet syndrome (febrile neutrophilic dermatosis), 
which can be an idiopathic disease or secondary to 
numerous conditions like malignant carcinomas, in-
fections, systemic disorders, drugs, etc. On finding 
recurrent oral ulcers, on the differential diagnosis 
it is also necessary to consider skin diseases, which 
can have a similar clinical picture, such as erythema 
multiforme, pemphigus and pemphigoid. Addition-
ally, in oral ulcers, the possibility of squamous cell 
carcinoma should be examined, especially if there 
are larger individual lesions. Furthermore, clinically 
similar can be infectious diseases, for example, lesions 
caused by HSV, Coxsackie stomatitis and syphilis (ul-
cus durum). It is necessary to think of granulomatous 
diseases (Crohn’s disease, sarcoidosis). Because of the 
multifactorial etiology of oral changes that point to 
aphthous ulcers and the association with a number of 
other disorders, a multidisciplinary approach to the 
disease is necessary. 
There is a need for public and patient education 
about the possibilities of work-up and treatment of 
RAS to decrease patient concern and improve their 
quality of life37. Health services that encompass medi-
cal workers and pharmacists should organize better 
education on the diagnostic procedures and treat-
ment of oral diseases, including RAS. Also, a lot is 
expected from randomized clinical researches, which 
are necessary to examine the potential use of different 
therapeutic possibilities.  
Conclusion
In the diagnosis of the disease, it is important to 
differentiate RAS from other oral ulcers, which are a 
manifestation of serious, even life-threatening diseas-
es. Considering that aphthous ulcers are accompanied 
by painful sensations and frequently have a recurrent 
course, the disease is very unpleasant. Therapeutic ap-
proach to the patient with aphthous ulcers is symp-
tomatic having no possibilities to prevent disease re-
currence. Yet, the disease prognosis is good at long 
term as the recurrences usually resolve at older age.
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Sažetak 
AFTOZNE ULCERACIJE KAO MULTIFAKTORIJALNI PROBLEM
A. Ujević, L. Lugović-Mihić, M. Šitum, L. Ljubešić, J. Mihić  i N. Troskot
Recidivirajući aftozni stomatitis (RAS) je poremaćaj obilježen recidivima ulceracija ograničenih na oralnu sluznicu. 
Mnogi specijalisti i istraživači iz područja oralne medicine i drugih područja u RAS-u ne prepoznaju jednu bolest, nego 
nekoliko patoloških stanja sa sličnim kliničkim značajkama. Iako je pravi uzrok nastanka nepoznat, postoje neki predispo-
nirajući čimbenici kao što su anemija zbog nedostatka željeza, folata i vitamina B skupine te cinka, neutropenija, lokalna 
trauma, emocionalni stres, metabolički poremećaji, hormonski poremećaji, kronične bolesti koje dovode do imunodefici-
jencije. Bolest dolazi u tri klinička oblika: male afte, velike afte i herpetiformne afte. Liječenje ovoga poremećaja uključuje 
lokalnu ili sustavnu primjenu kortikosteroida, imunostimulansa i vitaminsku terapiju. Zbog povezanosti manifestacija afti 
s različitim drugim bolestima potrebna je suradnja više struka i multidisciplinarni pristup. 
Ključne riječi: Afte; Recidivirajući aftozni stomatitis; Usna šupljina; Etiologija

